{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:06:38Z","timestamp":1785535598419,"version":"3.56.0"},"reference-count":132,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Interferon &amp; Cytokine Research"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>\n                    Immunoglobulin A (IgA) nephropathy is the most common primary glomerulonephritis worldwide, with no disease-specific treatment and up to 40% of patients progressing to kidney failure. IgA nephropathy (IgAN), characterized by IgA1-containing immunodeposits in the glomeruli, is considered to be an autoimmune disease in which the kidneys are injured as innocent bystanders. Glomerular immunodeposits are thought to originate from the circulating immune complexes that contain aberrantly\n                    <jats:italic toggle=\"yes\">O<\/jats:italic>\n                    -glycosylated IgA1, the main autoantigen in IgAN, bound by IgG autoantibodies. A common clinical manifestation associated with IgAN includes synpharyngitic hematuria at disease onset or during disease activity. This observation suggests a connection of disease pathogenesis with an activated mucosal immune system of the upper-respiratory and\/or gastrointestinal tract and IgA1 glycosylation. In fact, some cytokines can enhance production of aberrantly\n                    <jats:italic toggle=\"yes\">O<\/jats:italic>\n                    -glycosylated IgA1. This process involves abnormal cytokine signaling in IgA1-producing cells from patients with IgAN. In this article, we present our view of pathogenesis of IgAN and review how some cytokines can contribute to the disease process by enhancing production of aberrantly glycosylated IgA1. We also review current clinical trials of IgAN based on cytokine-targeting therapeutic approaches.\n                  <\/jats:p>","DOI":"10.1089\/jir.2022.0039","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T16:13:05Z","timestamp":1657123985000},"page":"301-315","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Cytokines and Production of Aberrantly\n                    <i>O<\/i>\n                    -Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy"],"prefix":"10.1177","volume":"42","author":[{"given":"Taylor","family":"Person","sequence":"first","affiliation":[{"name":"Department of Microbiology and Birmingham, Alabama, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Glenn","family":"King","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Birmingham, Alabama, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana V.","family":"Rizk","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Alabama at Birmingham, Birmingham, Alabama, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Novak","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Birmingham, Alabama, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Birmingham, Alabama, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4033-1360","authenticated-orcid":false,"given":"Colin","family":"Reily","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Birmingham, Alabama, USA."},{"name":"Department of Medicine University of Alabama at Birmingham, Birmingham, Alabama, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0244-2"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.060003969.x"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.150.9.3671"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.10.016"},{"issue":"1","key":"e_1_3_5_6_1","first-page":"i27","article-title":"Fc 040: Interim Results of Phase 1 and 2 Trials to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Bion-1301 in Patients with IgA Nephropathy","volume":"36","author":"Barratt J","year":"2021","unstructured":"Barratt J, , Hour B, , Sibley C, , Mittan A, , Roy S, , Stromatt C, , Endsley A, , Lo J, , Glicklich A. 2021. Fc 040: Interim Results of Phase 1 and 2 Trials to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Bion-1301 in Patients with IgA Nephropathy. Nephrol Dial Transplant, 36(Suppl 1):i27\u2013i28.","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_3_5_7_1","first-page":"iii137","article-title":"Mo039: The 24-Week Interim Analysis Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study of Atacicept in Patients with IgA Nephropathy and Persistent Proteinuria","volume":"3","author":"Barratt J","year":"2020","unstructured":"Barratt J, , Tumlin JA, , Suzuki Y, , Kao A, , Aydemir A, , Zima Y, , Appel G. 2020. Mo039: The 24-Week Interim Analysis Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study of Atacicept in Patients with IgA Nephropathy and Persistent Proteinuria. Nephrol Dial Transplant 35(Suppl, 3):iii137.","journal-title":"Nephrol Dial Transplant 35(Suppl"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.10.1453"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(88)80027-1"},{"issue":"9","key":"e_1_3_5_10_1","first-page":"694","article-title":"[Intercapillary Deposits of IgA-IgG]","volume":"74","author":"Berger J","year":"1968","unstructured":"Berger J, , Hinglais N. 1968. [Intercapillary Deposits of IgA-IgG]. J Urol Nephrol (Paris), 74(9):694\u2013695.","journal-title":"J Urol Nephrol (Paris)"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2007.10.001"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1998.2556"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13024"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(03)00365-4"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083901"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002748"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2012.01483.x"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.243"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy323"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112493"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.5.2327"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109998"},{"issue":"6","key":"e_1_3_5_23_1","first-page":"1002","article-title":"Is There Long-Term Value of Pathology Scoring in Immunoglobulin A Nephropathy?","volume":"35","author":"Coppo R","year":"2020","unstructured":"Coppo R, , D'Arrigo G, , Tripepi G, , Russo ML, , Roberts ISD, , Bellur S, , Cattran D, , Cook TH, , Feehally J, , Tesar V, , Maixnerova D, , Peruzzi L, , Amore A, , Lundberg S, , Di Palma AM, , Gesualdo L, , Emma F, , Rollino C, , Praga M, , Biancone L, , Pani A, , Feriozzi S, , Polci R, , Barratt J, , Del Vecchio L, , Locatelli F, , Pierucci A, , Caliskan Y, , Perkowska-Ptasinska A, , Durlik M, , Moggia E, , Ballarin JC, , Wetzels JFM, , Goumenos D, , Papasotiriou M, , Galesic K, , Toric L, , Papagianni A, , Stangou M, , Benozzi L, , Cusinato S, , Berg U, , Topaloglu R, , Maggio M, , Ots-Rosenberg M, , D'Amico M, , Geddes C, , Balafa O, , Quaglia M, , Cravero R, , Lino Cirami C, , Fellstrom B, , Floege J, , Egido J, , Mallamaci F, , Zoccali C, , Group E-EIW. 2020. Is There Long-Term Value of Pathology Scoring in Immunoglobulin A Nephropathy?. A Validation Study of the Oxford Classification for IgA Nephropathy (Valiga) Update. Nephrol Dial Transplant, 35(6):1002\u20131009.","journal-title":"A Validation Study of the Oxford Classification for IgA Nephropathy (Valiga) Update. Nephrol Dial Transplant"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.63"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141289"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099006"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/antib8040057"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-016-0251-5"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.5414\/CN107423"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016091043"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.50"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.787"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007091052"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1159\/000065465"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi962514"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.08.008"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03270410"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj20030407"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590031077.x"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2015.10.033"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.715253"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705577104"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411714200"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4889(02)00321-X"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(88)80039-8"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(88)80022-2"},{"issue":"4","key":"e_1_3_5_47_1","first-page":"202","article-title":"Familial IgA Nephropathy","volume":"312","author":"Julian BA","year":"1985","unstructured":"Julian BA, , Quiggins PA, , Thompson JS, , Woodford SY, , Gleason K, , Wyatt RJ. 1985. Familial IgA Nephropathy. Evidence of an Inherited Mechanism of Disease. N Engl J Med, 312(4):202\u2013208.","journal-title":"Evidence of an Inherited Mechanism of Disease. N Engl J Med"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90095-7"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006609"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002765"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3118"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74475"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041811-142014"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.4.1243.bloodjournal8641243"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194501"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00117"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz5807"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.1"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694787"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26628"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2148-7-120"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.563699"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106362"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016101103"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01543"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726215"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212254"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239064"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45563"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-00927-2"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00844284"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00065"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102593"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5425.260"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016050496"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr448"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67107.x"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00477.x"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031330"},{"key":"e_1_3_5_80_1","author":"Pers JO","year":"2005","unstructured":"Pers JO, , Daridon C, , Devauchelle V, , Jousse S, , Saraux A, , Jamin C, , Youinou P. 2005. BAFF Overexpression is Associated with Autoantibody Production in Autoimmune Diseases. Ann N Y Acad Sci 1050(34\u201339.","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190967"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104533"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2020.10.003"},{"key":"e_1_3_5_84_1","first-page":"38","article-title":"Aberrant O-Glycosylation of IgA1 in IgA Nephropathy: Single-Cell Transcriptome Analysis Identified a Subset of IgA1-Producing Cells with Altered Expression of C1GALT1 and MAPK","volume":"81","author":"Reily C","year":"2021","unstructured":"Reily C, , Crossman KD, , Julian AB, , Novak J. 2021. Aberrant O-Glycosylation of IgA1 in IgA Nephropathy: Single-Cell Transcriptome Analysis Identified a Subset of IgA1-Producing Cells with Altered Expression of C1GALT1 and MAPK. Soc Glycobiol, 81A:38.","journal-title":"Soc Glycobiol"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.2144\/btn-2018-0042"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0129-4"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/197548"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018111156"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.92"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.168"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1159\/000506853"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00745.x"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.015"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa264"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.14031119"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V132453"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302249"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.11.1747"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.333"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011060567"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv032"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1226"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.013"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13992-8"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215034"},{"issue":"5","key":"e_1_3_5_106_1","first-page":"2260","article-title":"MicroRNA196b Targets Cosmc in Pediatric IgA Nephropathy","volume":"21","author":"Sun Q","year":"2020","unstructured":"Sun Q, , Lan J, , Zhang H, , Zhou N, , Liang Y, , Liu X. 2020. MicroRNA196b Targets Cosmc in Pediatric IgA Nephropathy. Mol Med Rep, 21(5):2260\u20132266.","journal-title":"Mol Med Rep"},{"issue":"6","key":"e_1_3_5_107_1","first-page":"1668","article-title":"Aberrantly Glycosylated IgA1 in IgA Nephropathy Patients Is Recognized by IgG Antibodies with Restricted Heterogeneity","volume":"119","author":"Suzuki H","year":"2009","unstructured":"Suzuki H, , Fan R, , Zhang Z, , Brown R, , Hall S, , Julian BA, , Chatham WW, , Suzuki Y, , Wyatt RJ, , Moldoveanu Z, , Lee JY, , Robinson J, , Tomana M, , Tomino Y, , Mestecky J, , Novak J. 2009. Aberrantly Glycosylated IgA1 in IgA Nephropathy Patients Is Recognized by IgG Antibodies with Restricted Heterogeneity. J Clin Invest, 119(6):1668\u20131677.","journal-title":"J Clin Invest"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011050464"},{"issue":"2","key":"e_1_3_5_109_1","first-page":"629","article-title":"IgA1-Secreting Cell Lines from Patients with IgA Nephropathy Produce Aberrantly Glycosylated IgA1","volume":"118","author":"Suzuki H","year":"2008","unstructured":"Suzuki H, , Moldoveanu Z, , Hall S, , Brown R, , Vu HL, , Novak L, , Julian BA, , Tomana M, , Wyatt RJ, , Edberg JC, , Alarcon GS, , Kimberly RP, , Tomino Y, , Mestecky J, , Novak J. 2008. IgA1-Secreting Cell Lines from Patients with IgA Nephropathy Produce Aberrantly Glycosylated IgA1. J Clin Invest, 118(2):629\u2013639.","journal-title":"J Clin Invest"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00883-8"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.512277"},{"issue":"1","key":"e_1_3_5_112_1","first-page":"205","article-title":"Mo258 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Vis649, an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers: Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study","volume":"36","author":"Suzuki Y","year":"2021","unstructured":"Suzuki Y, , Mathur M, , Barratt J, , Engler F, , Yarbrough J, , Sloan S, , Oldach D. 2021. Mo258 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Vis649, an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers: Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study. Nephrol Dial Transpl, 36(Suppl 1):205\u2013206.","journal-title":"Nephrol Dial Transpl"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.797"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.103925"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.1.129"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.361"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5535"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.02.003"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00910121"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(01)00160-7"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020060823"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(88)80042-8"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1206793"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.04.004"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90073-6"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3216"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1159\/000505748"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.07.002"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq325"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1047"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021081086"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003099"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00722-3"}],"container-title":["Journal of Interferon &amp; Cytokine Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jir.2022.0039","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jir.2022.0039","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jir.2022.0039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:35:57Z","timestamp":1777455357000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jir.2022.0039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":132,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1089\/jir.2022.0039"],"URL":"https:\/\/doi.org\/10.1089\/jir.2022.0039","relation":{},"ISSN":["1079-9907","1557-7465"],"issn-type":[{"value":"1079-9907","type":"print"},{"value":"1557-7465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}